Programmed bacterial lysis in vivo alters host immune responses and microbial pathogenesis
Cell Reports · 2026-11 · 45 (11) · 118256
DOI: 10.1016/j.celrep.2026.118256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-11. Verfasst von Mareike Lembke und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Research Foundation, National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases, Harvard Digestive Diseases Center.
Abstract (Originalsprache)
Vibrio cholerae injects toxic type VI secretion system (T6SS) effectors to lyse sensitive intestinal commensals, but how this bacterial antagonism enhances mucosal host immune responses and its pathogenicity remains unknown. To mimic T6SS-mediated killing, we engineered V. cholerae lysis strains by using CRISPR interference (CRISPRi) to knockdown essential genes in peptidoglycan biogenesis or lipopolysaccharide (LPS) transport. Our results indicate that controlled bacterial lysis in vivo leads to divergent mucosal immune responses that directly modulate colonization and pathogenicity of a bystander, non-lysing V. cholerae ΔT6SS strain. Mass spectrometric analysis of the lysis debris revealed proinflammatory muropeptides correlating with these changes. We confirmed that oral co-administration of a synthetic peptidoglycan-derived metabolite with a V. cholerae ΔT6SS mutant, but not the wild type, shows dramatic enhancement of disease symptoms. These findings show that intestinal exposure to discrete bacterial cell wall metabolites can differentially modulate host innate immune responses and consequently bacterial pathogenesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA.
- Department of Pathology, Brigham and Women's Hospital, Boston MA 02115, USA; Harvard Medical School, Boston, MA 02115, USA.
- Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: john_mekalanos@hms.harvard.edu.
Förderung
- German Research Foundation
- National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
- Harvard Digestive Diseases Center
Zitieren
APA
Lembke, M., Simmons, D. P., Robins, W. P., Toska, J., Meader, B. T., & Mekalanos, J. J. (2026). Programmed bacterial lysis in vivo alters host immune responses and microbial pathogenesis. Cell Reports, 45(11), 118256. https://doi.org/10.1016/j.celrep.2026.118256
Vancouver
Lembke M, Simmons DP, Robins WP, Toska J, Meader BT, Mekalanos JJ. Programmed bacterial lysis in vivo alters host immune responses and microbial pathogenesis. Cell Reports. 2026;45(11):118256. doi:10.1016/j.celrep.2026.118256
BibTeX
@article{Lembke2026,
author = {Lembke, Mareike and Simmons, Daimon P and Robins, William P and Toska, Jonida and Meader, Bradley T and Mekalanos, John J},
title = {Programmed bacterial lysis in vivo alters host immune responses and microbial pathogenesis},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {11},
pages = {118256},
doi = {10.1016/j.celrep.2026.118256}
}
EUVIMED